Semen Cryopreservation and Reproductive Outcomes in Men with Hodgkin's Disease
Author Information
Author(s): Blackhall F H, Atkinson A D, Maaya M B, Ryder W D J, Horne G, Brison D R, Lieberman B A, Radford J A
Primary Institution: Cancer Research UK Department of Medical Oncology, Christie Hospital NHS Trust
Hypothesis
What are the effects of semen cryopreservation on reproductive outcomes in men treated for Hodgkin's disease?
Conclusion
Approximately one-quarter of men utilizing cryopreserved semen after treatment for Hodgkin's disease achieve a live birth.
Supporting Evidence
- 66% of men had normal semen quality before treatment.
- 27% of men utilized cryopreserved semen after a median follow-up of 10.1 years.
- Nine partners became pregnant resulting in 11 live births.
Takeaway
This study shows that many men with Hodgkin's disease can save their sperm before treatment, and some of them can have babies later using that sperm.
Methodology
The study analyzed semen quality and reproductive outcomes in a cohort of 122 men diagnosed with Hodgkin's disease between 1978 and 1990, using retrospective data collection and statistical methods.
Potential Biases
Potential biases include selection bias in the cohort and reporting bias in self-reported outcomes.
Limitations
The study is retrospective and may not account for all factors influencing semen utilization and reproductive outcomes.
Participant Demographics
Median age of participants was 24 years, with a range from 16 to 44 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website